Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese Multi-Institutional Study

Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese Multi-Institutional Study

Background. The CHAARTED and LATITUDE trials demonstrated a prolonged overall survival (OS) for metastatic hormone-naïve prostate cancer (mHNPC) patients who receive up-front docetaxel or abiraterone acetate. These studies used their own risk criteria: CHAARTED trial defines high- and low-volume dis...

Full description

Bibliographic Details
Main Authors: Takashi Kawahara, Shuko Yoneyama, Yoshio Ohno, Junpei Iizuka, Yasunobu Hashimoto, Hideyasu Tsumura, Ken-ichi Tabata, Yoshihiro Nakagami, Kazunari Tanabe, Masatsugu Iwamura, Hiroji Uemura, Yasuhide Miyoshi
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2020/7804932

Internet

http://dx.doi.org/10.1155/2020/7804932

Similar Items